Skip to main content

Adrata Research

The science of the pursuit.

Enterprise sales is a chain of decisions made by sellers and buyers under incomplete information. We study the moments that change its direction—from the first sentence to the room that makes the final call.

01

Field evidence

We examine the messages, meetings, account signals, buyer-room changes, and commitments attached to real pursuits.

02

Exploratory simulation

We use bounded synthetic buyer and seller roles to stress-test a hypothesis before looking for the same pattern in field evidence.

03

Measured outcomes

We compare what the team believed, what it chose, and what happened next. Synthetic results never substitute for buyer evidence.

Active research

Questions we are testing now.

We publish the question, the evidence we intend to examine, and the limits of the method before we publish a conclusion.

Active study

What earns the second look?

Which subject-line and opening cues earn attention when buyers have already learned to ignore the familiar patterns of synthetic outbound?

Method

Message and reply evidence, controlled variants, and exploratory inbox simulations across buyer roles and levels of account familiarity.

Field study

The move after the champion

When an enterprise pursuit is single-threaded, which next move most reliably expands the room without weakening the champion?

Method

Buyer-room changes, meeting sequences, relationship paths, commitments, and the observed outcome of the pursuit.

Protocol design

Can a pursuit be rehearsed?

Can distinct synthetic stakeholders expose weak assumptions in a message, meeting opener, or next step before a seller tests it with a buyer?

Method

Repeated role-based simulations with different incentives, authority, memory, and objections. Findings remain exploratory until field evidence agrees.

What we observe

The whole pursuit, decision by decision.

The details matter on their own. They matter more as a sequence. We study both the individual move and the account state it changes.

01

Earn attention

The moment before a buyer decides whether you are worth another second.

  • Subject line
  • First sentence
  • Message
  • Timing
  • Channel mix
  • Cadence
02

Enter the account

The path from outside the account to a person with the standing to move it.

  • Trigger
  • Entry point
  • Warm path
  • Relevance
  • First meeting
  • Meeting opener
03

Win the room

The people, pressure, and politics behind the decision your CRM cannot see.

  • Champion
  • Skeptic
  • Blocker
  • Power
  • Committee coverage
  • Multithreading
04

Move the decision

The commitments that turn interest into motion and motion into a decision.

  • Next step
  • Mutual commitment
  • Objection
  • Procurement
  • Close
  • No decision

Research agenda

Four questions. One account.

Attention

Which subject lines, openings, messages, channels, and cadences earn the next second without manufacturing relevance.

Access

How timing, triggers, relationships, and credible entry points change the path into an account.

The buyer room

How champions, skeptics, missing stakeholders, power, and quiet vetoes shape the decision.

Decision momentum

What makes a next step real, where qualified deals stall, and which commitments bring the pursuit back into motion.

Field discipline

Grounded in real pursuits.

Adrata connects message choices, account context, buyer-room movement, and outcomes. We separate observations from hypotheses, preserve the evidence behind a judgment, and keep every public claim inside what the work can support.

The goal is not more sales content. It is a cumulative understanding of how a consequential enterprise pursuit actually moves.

Simulation generates hypotheses. Buyers supply the evidence.

Synthetic stakeholders let us rehearse a bounded situation many ways: different incentives, levels of authority, objections, memories, and information. We use the variation to find fragile assumptions and candidate moves. We label those findings exploratory until real pursuit evidence supports them.